The risk of relapse in breast cancer patients is associated with MMP-9 gene polymorphism: a prospective study in a sample of the Iranian population

References

• Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68, 394–424. DOI: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Moody, S. E.; Perez, D.; Pan, T. C.; Sarkisian, C. J.; Portocarrero, C. P.; Sterner, C. J.; Notorfrancesco, K. L.; Cardiff, R. D.; Chodosh, L. A. The Transcriptional Repressor Snail Promotes Mammary Tumor Recurrence. Cancer Cell 2005, 8, 197–209. DOI: 10.1016/j.ccr.2005.07.009.
   PubMed Web of Science ®Google Scholar
• Kennecke, H.; Yerushalmi, R.; Woods, R.; Cheang, M. C.; Voduc, D.; Speers, C. H.; Nielsen, T. O.; Gelmon, K. Metastatic Behavior of Breast Cancer Subtypes. JCO 2010, 28, 3271–3277. [Database] DOI: 10.1200/JCO.2009.25.9820.
   PubMed Web of Science ®Google Scholar
• De Silva, S.; Tennekoon, K. H.; Karunanayake, E. H. Overview of the Genetic Basis toward Early Detection of Breast Cancer. Breast Cancer (Dove Med Press) 2019, 11, 71–80. DOI: 10.2147/BCTT.S185870.
   PubMed Web of Science ®Google Scholar
• Dawson, S. J.; Makretsov, N.; Blows, F. M.; Driver, K. E.; Provenzano, E.; Le Quesne, J.; Baglietto, L.; Severi, G.; Giles, G. G.; McLean, C. A.; et al. BCL2 in Breast Cancer: A Favourable Prognostic Marker across Molecular Subtypes and Independent of Adjuvant Therapy Received. Br. J. Cancer 2010, 103, 668–675. DOI: 10.1038/sj.bjc.6605736.
   PubMed Web of Science ®Google Scholar
• Sheikh, A.; Hussain, S. A.; Ghori, Q.; Naeem, N.; Fazil, A.; Giri, S.; Sathian, B.; Mainali, P.; Al Tamimi, D. M. The Spectrum of Genetic Mutations in Breast Cancer. Asian Pac. J. Cancer Prev. 2015, 16, 2177–2185. DOI: 10.7314/apjcp.2015.16.6.2177.
   PubMedGoogle Scholar
• Jabłońska-Trypuć, A.; Matejczyk, M.; Rosochacki, S. Matrix Metalloproteinases (MMPs), the Main Extracellular Matrix (ECM) Enzymes in Collagen Degradation, as a Target for Anticancer Drugs. J. Enzyme Inhib. Med. Chem. 2016, 31, 177–183. DOI: 10.3109/14756366.2016.1161620.
   PubMed Web of Science ®Google Scholar
• van ‘t Veer, L. J.; Dai, H.; van de Vijver, M. J.; He, Y. D.; Hart, A. A.; Mao, M.; Peterse, H. L.; van der Kooy, K.; Marton, M. J.; Witteveen, A. T.; et al. Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer. Nature 2002, 415, 530–536. DOI: 10.1038/415530a.
   PubMed Web of Science ®Google Scholar
• McGowan, P. M.; Duffy, M. J. Matrix Metalloproteinase Expression and Outcome in Patients with Breast Cancer: analysis of a Published Database. Ann. Oncol. 2008, 19, 1566–1572. DOI: 10.1093/annonc/mdn180.
   PubMed Web of Science ®Google Scholar
• Owyong, M.; Chou, J.; van den Bijgaart, R. J.; Kong, N.; Efe, G.; Maynard, C.; Talmi-Frank, D.; Solomonov, I.; Koopman, C.; Hadler-Olsen, E.; et al. MMP9 Modulates the Metastatic Cascade and Immune Landscape for Breast Cancer anti-Metastatic Therapy. Life Sci. Alliance 2019, 2(6). e201800226. DOI: 10.26508/lsa.201800226.
   Web of Science ®Google Scholar
• Lambert, A. W.; Pattabiraman, D. R.; Weinberg, R. A. Emerging Biological Principles of Metastasis. Cell 2017, 168, 670–691. DOI: 10.1016/j.cell.2016.11.037.
   PubMed Web of Science ®Google Scholar
• Yousef, E. M.; Tahir, M. R.; St-Pierre, Y.; Gaboury, L. A. MMP-9 Expression Varies according to Molecular Subtypes of Breast Cancer. BMC Cancer 2014, 14, 609. DOI: 10.1186/1471-2407-14-609.
   PubMed Web of Science ®Google Scholar
• Yuan, M.; Zhan, Q.; Duan, X.; Song, B.; Zeng, S.; Chen, X.; Yang, Q.; Xia, J. A Functional Polymorphism at miR-491-5p Binding Site in the 3’-UTR of MMP-9 Gene Confers Increased Risk for Atherosclerotic Cerebral Infarction in a Chinese Population. Atherosclerosis 2013, 226, 447–452. DOI: 10.1016/j.atherosclerosis.2012.11.026.
   PubMed Web of Science ®Google Scholar
• Pirooz, H. J.; Jafari, N.; Rastegari, M.; Fathi-Roudsari, M.; Tasharrofi, N.; Shokri, G.; Tamadon, M.; Sazegar, H.; Kouhkan, F. Functional SNP in microRNA-491-5p Binding Site of MMP9 3’-UTR Affects Cancer Susceptibility. J. Cell Biochem. 2018, 119, 5126–5134. DOI: 10.1002/jcb.26471.
   PubMed Web of Science ®Google Scholar
• Hu, Z.; Huo, X.; Lu, D.; Qian, J.; Zhou, J.; Chen, Y.; Xu, L.; Ma, H.; Zhu, J.; Wei, Q.; Shen, H. Functional Polymorphisms of Matrix Metalloproteinase-9 Are Associated with Risk of Occurrence and Metastasis of Lung Cancer. Clin. Cancer Res. 2005, 11, 5433–5439. DOI: 10.1158/1078-0432.CCR-05-0311.
   PubMed Web of Science ®Google Scholar
• Shen, J.; Li, Z.; Chen, J.; Song, Z.; Zhou, Z.; Shi, Y. SHEsisPlus, a Toolset for Genetic Studies on Polyploid Species. Sci. Rep. 2016, 6, 24095. DOI: 10.1038/srep24095.
   PubMed Web of Science ®Google Scholar
• Quintero-Fabián, S.; Arreola, R.; Becerril-Villanueva, E.; Torres-Romero, J. C.; Arana-Argáez, V.; Lara-Riegos, J.; Ramírez-Camacho, M. A.; Alvarez-Sánchez, M. E. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol. 2019, 9, 1370. DOI: 10.3389/fonc.2019.01370.
   PubMed Web of Science ®Google Scholar
• Merdad, A.; Karim, S.; Schulten, H. J.; Dallol, A.; Buhmeida, A.; Al-Thubaity, F.; Gari, M. A.; Chaudhary, A. G.; Abuzenadah, A. M.; Al-Qahtani, M. H. Expression of Matrix Metalloproteinases (MMPs) in Primary Human Breast Cancer: MMP-9 as a Potential Biomarker for Cancer Invasion and Metastasis. Anticancer Res. 2014, 34, 1355–1366.
   PubMed Web of Science ®Google Scholar
• Liu, D.; Guo, H.; Li, Y.; Xu, X.; Yang, K.; Bai, Y. Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis. PLoS. One 2012, 7, e31251. DOI: 10.1371/journal.pone.0031251.
   PubMedGoogle Scholar
• Przybylowska, K.; Kluczna, A.; Zadrozny, M.; Krawczyk, T.; Kulig, A.; Rykala, J.; Kolacinska, A.; Morawiec, Z.; Drzewoski, J.; Blasiak, J. Polymorphisms of the Promoter Regions of Matrix Metalloproteinases Genes MMP-1 and MMP-9 in Breast Cancer. Breast Cancer Res. Treat. 2006, 95, 65–72. DOI: 10.1007/s10549-005-9042-6.
   PubMed Web of Science ®Google Scholar
• Pellikainen, J. M.; Ropponen, K. M.; Kataja, V. V.; Kellokoski, J. K.; Eskelinen, M. J.; Kosma, V. M. Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis. Clin. Cancer Res. 2004, 10, 7621–7628. [Database] DOI: 10.1158/1078-0432.CCR-04-1061.
   PubMed Web of Science ®Google Scholar
• Song, J.; Su, H.; Zhou, Y. Y.; Guo, L. L. Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients: A Meta-Analysis. Asian Pac. J. Cancer Prev. 2013, 14, 1615–1621. DOI: 10.7314/apjcp.2013.14.3.1615.
   PubMedGoogle Scholar
• Awakura, Y.; Ito, N.; Nakamura, E.; Takahashi, T.; Kotani, H.; Mikami, Y.; Manabe, T.; Kamoto, T.; Habuchi, T.; Ogawa, O. Matrix Metalloproteinase-9 Polymorphisms and Renal Cell Carcinoma in a Japanese Population. Cancer Lett. 2006, 241, 59–63. DOI: 10.1016/j.canlet.2005.10.005.
   PubMed Web of Science ®Google Scholar
• Brooks, R.; Kizer, N.; Nguyen, L.; Jaishuen, A.; Wanat, K.; Nugent, E.; Grigsby, P.; Allsworth, J. E.; Rader, J. S. Polymorphisms in MMP9 and SIPA1 Are Associated with Increased Risk of Nodal Metastases in Early-Stage Cervical Cancer. Gynecol Oncol. 2010, 116, 539–543. DOI: 10.1016/j.ygyno.2009.09.037.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Jin, G.; Li, J.; Zhang, L. Association between Four MMP-9 Polymorphisms and Breast Cancer Risk: A Meta-Analysis. Med. Sci. Monit. 2015, 21, 1115–1123. DOI: 10.12659/MSM.893890.
   PubMed Web of Science ®Google Scholar
• Chen, D. N.; Song, C. G.; Yu, K. D.; Jiang, Y. Z.; Ye, F. G.; Shao, Z. M. A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse. PLoS One 2015, 10, e0133184. DOI: 10.1371/journal.pone.0133184.
   Web of Science ®Google Scholar
• Lee, Y. J.; Oh, C. S.; Choi, J. M.; Park, S.; Kim, S. H. mu-Opioid Receptor Polymorphisms and Breast Cancer Recurrence in Adult Korean Women Undergoing Breast Cancer Surgery: A Retrospective Study. Int. J. Med. Sci. 2020, 17, 2941–2946. DOI: 10.7150/ijms.49297.
   PubMed Web of Science ®Google Scholar
• Teh, L. K.; Mohamed, N. I.; Salleh, M. Z.; Rohaizak, M.; Shahrun, N. S.; Saladina, J. J.; Shia, J. K. S.; Roslan, H.; Sood, S.; Rajoo, T. S.; et al. The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: polymorphisms of CYP2D6 and ABCB1. AAPS J. 2012, 14, 52–59. DOI: 10.1208/s12248-011-9313-6.
   PubMed Web of Science ®Google Scholar